Female genital mutilation (FGM) includes procedures involving the partial or total removal of the external female genitals for non-therapeutic reasons. They can have negative psychosexual and health consequences that need specific care. In this paper, we review some key knowledge gaps in the clinical care of women with FGM, focusing on obstetric outcomes, surgical interventions (defibulation and clitoral reconstruction), and the skills and training of healthcare professionals involved in the prevention and management of FGM. We identify research priorities to improve the evidence necessary to establish guidelines for the best multidisciplinary care, communication, and prevention, and to improve health-promotion measures for women with FGM.
Introduction
Female genital mutilation (FGM) are procedures involving the partial or total removal of the external female genitalia for non-therapeutic reasons. FGM violates the human rights of women and girls, has no health benefits, and can have significant, negative, psychophysical health outcomes. [1] [2] [3] [4] [5] [6] The World Health Organization (WHO) defines four types of FGM (Table 1) . These practices are prevalent in eastern and western Africa, among some ethnic groups in Indonesia, Malaysia, and areas of the Persian Gulf, 1, 2 and are increasingly common in the Western world as a result of migration. More than 125 million girls and women have been subjected to FGM, and at least 3 million girls are at risk every year. 2 Migration trends have resulted in an increased prevalence of FGM in Europe, USA, Australia, and Canada. [3] [4] [5] [6] [7] According to the European Institute for Gender Equality, women with FGM live in at least 13 European countries. 3 The estimates vary from 170-350 women in Hungary (2012) to 65 790 in the UK (2007). 3 International attention has focused on efforts to end these practices. In 2012, the UN General Assembly adopted a resolution on eliminating FGM, and intensified action was called for across policy, community, and health sectors. 8 Despite efforts to enact laws, and implement community education programmes, support groups, medical guidelines, new surgical techniques, and specialized multidisciplinary centres for the care of women with FGM, progress has been limited in both preventing FGM, especially in developing countries, and caring for girls and women who have already undergone FGM. Several factors have contributed to a delay in eradicating FGM. These factors range from structural/policy to sociocultural issues and issues related to health-system capacity. 8 Key knowledge gaps remain for both the prevention of FGM and evidence-based care to optimize health outcomes for girls and women with genital mutilation.
As important as identifying effective policies and interventions to eliminate FGM is the need for evidence on how to minimize negative health outcomes for women living with FGM. This includes improving the knowledge base about obstetrical and gynaecological consequences, as well as improved provider training. There is an urgent need to strengthen providers' capacity to deliver high-quality, evidence-based care for women with FGM, as well as to prevent healthcare workers from providing FGM (medicalisation of FGM).
In this paper we review the existing evidence on obstetric outcomes, surgical interventions (defibulation and clitoral reconstruction), and skills and training of health care professionals involved in the prevention and management of FGM. Key knowledge gaps in the clinical care of women living with FGM and priority research areas are identified.
Methods
Current recommendations regarding the health care of women with FGM differ among countries. We reviewed the available literature about the clinical care of women with FGM to identify the existing evidence base and research gaps.
We searched the PubMed database for articles regarding the care of women with FGM in any country, published in any language, from 1986 to January 2014. A combination of medical subject headings (MeSH), text, and keywords were used. Search terms included: female genital mutilation; female genital cutting; female genital surgeries; FGM; FGC; FGM/C; clitoris; defibulation; and clitoral reconstruction. Studies of all design and quality were considered. We included reviews, and retrospective and prospective cohort studies providing quantitative and qualitative data, audits, case reports, comments, guidelines, and experts' opinions. Articles reporting on any health consequence, complication, or clinical management of FGM were included. We included publications about healthcare providers' knowledge of FGM. We did not include studies pertaining to cosmetic surgery of the female genitalia.
The evidence was then categorised by themes. We did not subsequently include all possible aspects of clinical care in our review, but instead focused on four areas, prioritised by the WHO FGM Advisory Group. Thematic areas were selected and prioritised on the basis of the absence of clinical guidelines, controversy in management, and the potential to significantly affect the health of women living with FGM. Papers were reviewed and summarised by all three authors. The themes and evidence summaries for each area were presented in February 2014 at a WHO technical consultation including global participants with expertise in FGM research and programmes. Participants identified specific research priorities for WHO to support the development of evidence-based clinical guidelines.
Results
Four thematic areas in the care of women with FGM were identified that had significant evidence gaps and controversy regarding optimal management. Themes identified were: (1) obstetric outcome and postpartum perineal reeducation; (2) defibulation outside of pregnancy or labour; (3) clitoral reconstruction; and (4) training, skills, and confidence of healthcare providers. Our search identified research articles (all study designs), guidelines, expert opinions, commentaries, and policy statements. In the section below we summarize, by thematic area, the research and guidelines identified. Policy statements, commentaries, and expert opinions are referenced only for contextual information.
With respect to obstetric outcomes and postpartum perineal re-education, 24 references were identified (Table 2) : 16 research studies; [9] [10] [11] [12] [14] [15] [16] [17] [18] 20, 24, 27, [29] [30] [31] [32] five clinical guidelines; 21, 23, 25, 26, 28 one expert opinion; 22 one policy statement; 19 and one letter to the editor. 13 On defibulation performed outside of pregnancy or labour, nine references were identified: 21, 22, [33] [34] [35] [36] [37] [38] [39] four research articles; [34] [35] [36] 39 one guideline; 21 three expert opinions; 22, 33, 37 and one case report. 38 On clitoral reconstruction, ten relevant references were identified: 22, 26, [39] [40] [41] [42] [43] [44] [45] [46] five research articles; [39] [40] [41] [42] [43] and five expert opinions, 22 guidelines, 26 or commentaries. [44] [45] [46] Twelve studies on the role of healthcare providers were identified. 17, 31, [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] We summarize the evidence and guidelines identified and reviewed by each thematic area, and then highlight the proposed research priorities for each topic ( Table 2 ).
Summary of existing evidence
Obstetric outcome and postpartum perineal re-education Obstetric outcome. Studies conducted in Africa have shown that FGM is associated with increased risks of caesarean section, postpartum haemorrhage, episiotomy, extended maternal hospital stay, resuscitation of the infant, low-birthweight infant, and inpatient perinatal death. 9, 12, 13 Studies performed in Western settings, however, suggest that a high standard of obstetric care (e.g. defibulation and follow-up of the pregnancy) can minimise these risks. [14] [15] [16] [17] Risks of episiotomy or third-degree perineal tears seem to remain significantly higher in some studies. 15 A recent systematic review suggested a disparity between women with and without FGM for prolonged labour, obstetric lacerations, instrumental delivery, obstetric haemorrhage, and difficult delivery. The authors encourage additional studies to better investigate if true causality exists. 18 It has been reported that serious obstetric complications are caused by the scarring and inelastic tissue resulting from FGM; 15 however, few studies have focused on the different degrees and types of scar, depending on the kind of cutting and complications. Miscommunication, distrust, delays in seeking care, and avoiding medical interventions can contribute to negative obstetric outcome. 14, 19 Significant limitations in the current literature exist. Studies are limited by being of observational design and of small sample size. The FGM types of the women included are often only self-reported, instead of being documented with a vulvar exam. 18, 20 No randomised controlled trials (RCTs) on interventions to improve the outcome and the quality of life of pregnant women with FGM were identified. 20 Additionally, existing evidence does not differentiate complications and obstetric outcome for the different types of FGM, nor does it adequately control for healthcare access, use, and quality: factors that influence outcome. Few studies explored the indications for caesarean section or assisted delivery in women with FGM.
Defibulation is a surgery performed in women who have undergone type-III FGM. Partial defibulation exposes the vaginal opening and the urethral meatus only, whereas total defibulation also uncovers clitoral tissue. 10, 11, [21] [22] [23] Defibulation can be performed both during a pregnancy (antenatal or intrapartum) and outside of pregnancy. The timing of defibulation in pregnant women is controversial, and many gaps in the evidence exist. Because of these gaps the available recommendations on the timing of defibulation during pregnancy or labour, as well as on episiotomy, differ A retrospective cohort study reported on outcomes by timing of defibulation during pregnancy. 17 A total of 253 women with type-III FGM who gave birth at a single hospital in the UK during 1 year were included. Of this cohort, nine women were defibulated antenatally, 18 in labour, 18 women declined defibulation, and 208 had undergone defibulation in a previous pregnancy. Although not significant, there was a trend towards increased blood loss and spontaneous tears in the case of intrapartum defibulation. Women with an antenatal defibulation were noted to have a higher episiotomy rate (P < 0.01). 17 The small sample size precludes any definitive conclusion and additional research is needed.
Women with FGM have been reported as being at increased risk for vaginal and urinary infections throughout their life. 29, 32 This evidence is limited to studies with small samples, 32 or to prospective cohort studies of women or girls with mostly type-III FGM. 29 The risk of such infections during pregnancy is not known.
Postpartum perineal re-education. Until now, studies on the obstetric outcome of women with FGM have paid little or no attention to the postpartum period; however, if there is an increased risk of episiotomy, perineal lacerations, 9, 12 or third-degree tear, 15 a greater incidence of long-term perineal complications such as urinary or stool incontinence would be expected.
Defibulation not performed during pregnancy or labour
No prospective multicentre study exists about sexuality, body image, and the treatment of complications of type-III FGM after defibulation performed outside of pregnancy/ delivery. Few studies, with small sample sizes have been published on this subject. This surgery is technically simple and can significantly improve infibulated women's health. 21, 22, [34] [35] [36] 39 Limited evidence (case reports) suggests that defibulation can effectively treat symptoms such as dysmenorrhea, dyspareunia, [34] [35] [36] 39 and urinary complications, including overactive bladder, by removing the obstacle of the bridge scar. 21, [34] [35] [36] [37] [38] According to observational studies and expert opinions, women may need specific counselling before and after defibulation, as this represents an important change in culture, physiology (e.g. micturition), and body image. 11, 22, 33 Some women may not want to feel completely opened, and ask for the incision to be stopped just above the urethral meatus to ensure normal micturition. 22, 33 It has also been reported that some married women will only accept, or ask for, defibulation with the husband's agreement. The operation is then kept secret to avoid exposing the husband to ridicule from their own family and community, as the defloration of the scar is a demonstration of virility. 33, 34 Women may have a variety of common medical or psychosexual conditions, without disclosing to their healthcare provider that they have undergone type-III FGM. Likewise, they may not request defibulation. Caregivers must enquire specifically and appropriately about genital mutilation and infibulation, as part of a comprehensive gynaecological history, and explain the option of defibulation. 31 Improving caregivers' knowledge on the common doubts and fears manifested by women concerning the procedure should improve preoperative counselling and care, and may improve acceptance rates of defibulation. 25 Defibulation is recommended during delivery and not during pregnancy in order to avoid any 'unnecessary trauma' for women. 24 As the obstetrical outcome does not change if defibulation is performed during pregnancy or at delivery, defibulation should be performed during pregnancy only if vaginal examination is impossible. 25 Gynaecology without borders, Ministry of Health and Sports of France (2010) 26 Defibulation is recommended during the second stage of labour or during pregnancy. Opening up of infibulation during antenatal period or during delivery, 27, 28 without details on when.
Clitoral reconstruction
The impact of FGM on sexuality, including orgasm, is unknown. Limited research, with significant methodological limitations, has investigated this topic. 39 It has been reported that healthy women with FGM are able to reach orgasm; 34, 39 however, the published literature is not conclusive. No study has differentiated between women according to the type of FGM and clitoral integrity. Furthermore, no study has compared the sexuality of women with FGM with an intact or cut clitoris. 39 No study considered fundamental factors such as body image and partner relationship, which significantly contribute to sexuality.
Clitoral reconstruction is a relatively new surgical technique that involves the resection of the scar covering the clitoral stump, sectioning the suspensory ligament, removing the fibrosis surrounding the mobilized stump, and repositioning it as a neoglans. 26, [40] [41] [42] The technique described first by Thabet, 43 and by Fold es, 40, 41 reduced clitoral pain and improved pleasure in about 40% of 841 women. It was reported to have a complications rate (mostly haematoma, dehiscence, and infection) of 5.3% and a readmission rate of 3.7%. 40 Outcomes were evaluated in four studies, [40] [41] [42] [43] by empiric scales, 44 from an aesthetic point of view, 44 and only in one case at 1 year post surgery. 40 This operation is covered by health insurance in France, 40 and is becoming increasingly advertised in the Western world and in some African countries, 42 in spite of debates and concerns about its potential psychophysical harmful consequences. 45, 46 The surgery is often seen as a way of promoting female completeness and supporting gender identity, rather than improving sexual pleasure. 22, 44 Few studies and no official medical guidelines exist on clitoral reconstruction, a surgery with health, sociocultural, gender, anthropological, and psychosexual implications. 44 Young circumcised women growing up in Western countries, reported to be at higher risk of sexual problems, 40 can sometimes ask for surgery even before having started sexual intercourse, because of negative expectations regarding sexuality or for aesthetic reasons. 44 It has been stressed that clitoral reconstruction should always be accompanied by standardised and culturally competent counselling and explanations on FGM, female anatomy, physiology, and sexuality. A key component of clitoral reconstructive surgery is psychosexual evaluation and follow-up. 44 Training, skills, and confidence of healthcare providers Provider training is an essential component of improving clinical outcomes for women. Currently FGM is not included in the curriculum of most medical, nurse, midwifery, and public health training, 47, 48 and recommendations about clinical management, refibulation, and legislation on FGM are not well known. 49 Some studies have investigated the knowledge, awareness, and attitudes of healthcare professionals in both Western and African settings. 17, 31, [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] In Canada, women with FGM were reported to be unhappy with both clinical practice and the quality of care received during pregnancy and childbirth. 49 In the UK, significant gaps were found in the provision of appropriate antenatal care for women who have undergone FGM, and their at-risk daughters, despite available guidelines. This is believed to arise from insufficient awareness, a failure to identify FGM, and an absence of training. 50 Studies have described a lack of provider awareness of the prevalence, diagnosis, and management of FGM, and difficulties in identifying and classifying FGM according to the WHO classification. [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] A UK survey found that only half of the 79 participants were aware that there are four types of FGM, 51 and in another study, only 58% of the 45 respondents were able to list the different categories. 52 In Egypt, a country with a high prevalence of FGM, poor knowledge on the issue was reported among medical students. 53 In Sudan, another country with a high prevalence of FGM, a study among midwives reported that 80% of the respondents used to practice FGM, but that only 7% were able to correctly identify the four types. 54 A study on a sample of 39 women with FGM in the UK showed that often the FGM was not identified until the onset of labour. 50 In Norway, a qualitative study found both disempowerment and a lack of awareness among gynaecologists and midwives regarding FGM and infibulation as a medical problem. 56 In Switzerland, opportunities to identify FGM are frequently missed (37%) or the FGM type is often misclassified (23%), in spite of the available guidelines for gynaecologists, obstetricians, and midwives, professionals who must be trained to correctly screen, refer, and care for women with FGM. 55 A lack of visual documentation on the different types of FGM, complications, and surgeries perpetuates the challenges that providers face in correctly identifying FGM subtypes. Some pictures of FGM and their complications are available in articles published in the literature; 57 however, no didactic atlas exists. In addition, textbooks (e.g. Netter's Obsterics & Gynaecology) may present a different classification of FGM than the official classification proposed by the WHO:
1 for example, type-IV FGM is illustrated as a severe infibulation (type III), instead of FGM by pricking, piercing, incising, scraping, or cauterisation. 58 The lack of recognition or misclassification of FGM jeopardises the health care of women: no recognition impedes diagnosis, which precludes appropriate care, counselling, and treatment. Appropriately trained personnel could lead to improved communication, diagnosis, and documentation, and to better health care and the prevention of this practice for future generations. 55 Training of healthcare providers by individuals with expertise in FGM should include cultural, psychosexual, and legal information, along with medical and surgical care and obstetric management. It should include didactic pictures and videos, discuss the importance of prevention, and address the medicalisation of FGM. Communication simulations, or role play, may improve provider comfort and ability to address the sensitive sexual and cultural issues encompassed by FGM. Some resources are already available. 21, 57, 59 As one common identified problem is classification, caregivers could be provided with a pocket flyer with pictures and descriptions of the four types of FGM, the countries considered at risk, and the main complications to be recognised during the vulvar examination. 55 
Summary of research gaps
Obstetric outcome and postpartum perineal re-education Obstetric outcome. Obstetric outcomes should be prospectively evaluated adjusting the results for age, socio-economic status, reproductive history, health, diseases affecting the pregnancy, and education, as performed by WHO in 2006. 9 Importantly, results should also be interpreted in the context of healthcare use and quality, such as the type of health care available, or the presence of a dedicated clinic for women with FGM. It is fundamental to distinguish the obstetric outcome for each type of FGM and to register the type of delivery, with the reason for assisted delivery or caesarean section indicated, and the stage of labour at which emergency caesarean section is performed. The definitions used to measure common outcomes should be standardised (e.g. prolonged labour).
Evidence on the ideal timing of defibulation during pregnancy is urgently needed. It is not known if the timing of defibulation affects the acceptability of the procedure or health outcomes, or whether the demand for postpartum reinfibulation varies with the timing of defibulation during pregnancy. One could hypothesise that women who had their genitalia defibulated during pregnancy have the opportunity to become accustomed to the new body image, and do not experience postpartum and post-defibulation anatomical and physiological changes at the same time. Defibulation is technically simple, but may require supportive care as the woman can experience doubts, and resistance or fear of exclusion from her own community, and can dislike the new body image and physiology. 30 A well--designed study, with adequate sample size, that prospectively compares antepartum and intrapartum defibulation, with respect to blood loss, rates of episiotomy, perineal lacerations, demand of reinfibulation (postpartum restitching), and acceptability to women is needed.
Evidence on how to manage intrapartum defibulation is needed. Defibulation in pregnancy, at the first and at the second stage of labour, should be prospectively compared for blood loss, rate of episiotomy, perineal tear, demand for reinfibulation, and acceptance and satisfaction of the women. The choice of the woman between defibulation in pregnancy or at delivery should be evaluated according to the gestational age at which the woman is referred: if women are informed about defibulation only at the end of the pregnancy, they will not have a choice between defibulation during pregnancy or in labour. The age of pregnancy at referral could also be an indicator of the attention paid to FGM by caregivers, who often think about FGM only when the delivery is approaching.
Evidence is needed on the incidence of urinary tract and vaginal infections during pregnancy, and their health consequences in women with FGM. It is unknown whether antenatal defibulation, in the case of type III, could decrease the frequency of such infections.
Postpartum perineal re-education. Further studies could evaluate long-term postpartum complications, such as prevalence of incontinence postpartum, or the effectiveness of treatments, such as perineal re-education (e.g. biofeedback or Kegel exercises). Perineal re-education could improve not only lower urinary tract symptoms and dyspareunia, but could also increase the woman's self-knowledge of anatomy and physiology, which may improve satisfaction with genitalia image after delivery. Improved satisfaction with vulvar appearance may lead to decreased requests for postpartum reinfibulation.
Defibulation not performed during pregnancy or labour Further studies should investigate how defibulation can improve infibulated women's health and sexuality, and how it modifies body image. Prospective studies should focus on the women's motivations and medical indications for the procedure, the closure type (subtypes of type-III FGM, with or without the cutting of the clitoris), the type of defibulation (partial or total) preferred by women, the resolution of symptoms after surgery (e.g. dysmenorrhea, urinary complications, and genitourinary infections), and the anaesthesia (general or local) preferred by women. Intraoperative and postoperative complications should be recorded. Sexual function and body image before and after defibulation should be evaluated with validated tools. When and where women seek care for defibulation, who performs it, and what access and care is offered could also be investigated.
Clitoral reconstruction
Future sexuality research in women with FGM, including clitoral reconstruction, should clearly define appropriate control groups, adjust for key demographic differences, 39 and choose or create validated questionnaires to measure sexuality outcomes, including orgasm. Important research questions exist concerning clitoral reconstruction, such as the impact of this surgery on the health outcomes of vulvar pain and sexual functioning.
The preoperative expectations of patients and the degree of postoperative satisfaction in terms of body image, and global sexual function, are relevant outcomes to assess with this surgery. An improved understanding of the roles played by anatomy, body self-image, and identity is needed. 44 Future studies should focus on identifying the motivations of women asking for clitoral reconstruction, such as social and aesthetic reasons, change of body image, ideal of beauty, factors linked with gender identity, and feelings of rehabilitation or empowerment. Studies on the best care of young, migrant, circumcised women growing up in host countries are also needed. These young women are reported to be at greater risk of sexual problems than adult women with FGM in their original countries. 40, 59 Training, skills, and confidence of healthcare providers Future studies should evaluate whether, in addition to a lack of time and training on FGM, the present counselling of caregivers and practice result from a desire to avoid a subject that is considered taboo, or from a concern about stigmatising women with their questions. Training including cultural skills in discussing sexuality and FGM may improve counselling and care. It is crucial to study the beliefs on anatomy, physiology, and sexuality of women with FGM held by caregivers in both Western settings and in countries where FGM is practiced. If providers managing an FGM complication consider FGM as an irreversible and untreatable condition, they may not offer appropriate care and counselling.
Further studies on healthcare providers, in particular maternity staff and paediatricians, interpreters, and social workers, could help to assess knowledge and skills on FGM, personal emotional distress, reactions, and fears, confidence, personal beliefs, willingness to talk about FGM with a woman affected, and documentation of the medical file. According to the results, measures could be taken to improve communication, FGM diagnosis and care, and documentation.
The effectiveness of the implemented measures should be evaluated. Evaluation measures could include questionnaires administered before and after training, or behaviour changes in patient care (although these latter changes could be difficult to study).
Conclusion
There is an urgent need for well-designed research to inform evidence-based guidelines, and to improve the health care of women and girls with FGM. Future studies should focus on addressing existing research gaps such as obstetric outcome, complications, sexuality, and therapeutic surgeries. They should take into consideration the diversity of women with FGM: different types of cutting, origins, cultures, experience, complications, and migration. Ideally, future studies should be multicentre and prospective, and should involve countries where FGM is practiced as well as countries of migration. Circumcised women's groups should also be involved to help us understand what research they want and need. Training of caregivers represents another large field of work and research. Evidence will help to establish guidelines for the best multidisciplinary care, communication, prevention, and improvement of health promotion measures.
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